TrialInfectious diseases of poverty2021

Safety and immunogenicity of inactivated SARS-CoV-2 vaccine in high-risk occupational population: a randomized, parallel, controlled clinical trial.

Yongliang Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.